Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances

被引：3
|
作者：
Aguilar, Gerardo [1 ,2 ,3 ]
Ferriols, Rafael [2 ,3 ,4 ]
Martinez-Castro, Sara [1 ]
Ezquer, Carlos [3 ,4 ]
Pastor, Ernesto [1 ]
Carbonell, Jose A. [1 ]
Alos, Manuel [2 ,3 ,4 ]
Navarro, David [2 ,3 ,5 ]
机构：
[1] Hosp Clin Univ Valencia, Anesthesiol & Crit Care Dept, Crit Care Unit, Valencia, Spain
[2] INCLIVA Hlth Res Inst, Ave Menendez & Pelayo 4, Valencia 46010, Spain
[3] Univ Valencia, Sch Med, Ave Blasco Ibanez 15, Valencia 46010, Spain
[4] Hosp Clin Univ Valencia, Dept Pharm, Ave Blasco Ibanez 17, Valencia 46010, Spain
[5] Hosp Clin Univ Valencia, Dept Microbiol, Ave Blasco Ibanez 17, Valencia 46010, Spain
来源：
CRITICAL CARE | 2020年 / 24卷 / 01期
关键词：
D O I：
10.1186/s13054-019-2724-y
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
    Gerardo Aguilar
    Rafael Ferriols
    Sara Martínez-Castro
    Carlos Ezquer
    Ernesto Pastor
    Jose A. Carbonell
    Manuel Alós
    David Navarro
    Critical Care, 24
  • [2] Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
    Honore, Patrick M.
    Mugisha, Aude
    Barreto Gutierrez, Leonel
    Redant, Sebastien
    Kaefer, Keitiane
    Gallerani, Andrea
    De Bels, David
    CRITICAL CARE, 2019, 23 (01):
  • [3] Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
    Patrick M. Honore
    Aude Mugisha
    Leonel Barreto Gutierrez
    Sebastien Redant
    Keitiane Kaefer
    Andrea Gallerani
    David De Bels
    Critical Care, 23
  • [4] Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
    Gerardo Aguilar
    Rafael Ferriols
    Sara Martínez-Castro
    Carlos Ezquer
    Ernesto Pastor
    José A. Carbonell
    Manuel Alós
    David Navarro
    Critical Care, 23
  • [5] Pharmacokinetics of Ceftolozane-Tazobactam during Prolonged Intermittent Renal Replacement Therapy
    Rawlins, Matthew
    Cheng, Vesa
    Raby, Edward
    Dyer, John
    Regli, Adrian
    Ingram, Paul
    McWhinney, Brett C.
    Ungerer, Jacobus P. J.
    Roberts, Jason A.
    CHEMOTHERAPY, 2018, 63 (04) : 203 - 206
  • [6] Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
    Aguilar, Gerardo
    Ferriols, Rafael
    Martinez-Castro, Sara
    Ezquer, Carlos
    Pastor, Ernesto
    Carbonell, Jose A.
    Alos, Manuel
    Navarro, David
    CRITICAL CARE, 2019, 23 (1):
  • [7] Ex vivo Ceftolozane/Tazobactam Clearance during Continuous Renal Replacement Therapy
    Chaijamorn, Weerachai
    Shaw, Alexander R.
    Lewis, Susan J.
    Mueller, Bruce A.
    BLOOD PURIFICATION, 2017, 44 (01) : 16 - 23
  • [8] Clinical outcomes of ceftolozane-tazobactam dosing in patients with sepsis undergoing renal replacement therapies
    El Nekidy, Wasim S.
    Al Ali, Mooza
    Abidi, Emna
    Ghazi, Islam M.
    Attallah, Nizar
    El Lababidi, Rania
    Hijazi, Fadi
    Mallat, Jihad
    CLINICAL NEPHROLOGY, 2023, 100 (03) : 126 - 131
  • [9] Impact of Renal Function on the Pharmacokinetics and Safety of Ceftolozane-Tazobactam
    Wooley, Myra
    Miller, Benjamin
    Krishna, Gopal
    Hershberger, Ellie
    Chandorkar, Gurudatt
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) : 2249 - 2255
  • [10] Pharmacokinetics of ceftolozane/tazobactam continuous infusion on renal replacement therapy: A pediatric case report
    Collignon, Charlotte
    Gana, Ines
    Benaboud, Sihem
    Toubiana, Julie
    Castelle, Martin
    Oualha, Mehdi
    de Marcellus, Charles
    THERAPIE, 2022, 77 (05): : 616 - 620
12345